Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp495 | Other diseases of bone and mineral metabolism | ECTS2013

Long-term effects of symptomatic vs intensive bisphosphonate therapy for Paget's disease of bone: the PRISM-EZ study

Goodman Kirsteen , MacLennan Graeme , Fraser William , Selby Peter , Ralston Stuart

Paget’s disease of bone (PDB) is a common metabolic bone disease characterised by increased and disorganised bone remodelling affecting one or more skeletal sites. Bisphosphonates are highly effective at suppressing bone turnover in PDB but it remains unclear whether greater suppression of bone turnover improves clinical outcome. In the PRISM study, we previously reported that PDB patients randomised to ‘intensive’ treatment aimed at normalising alkaline phospha...